Exome Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.83M | Buy |
115,817
+12,334
| +12% | +$408K | 2.85% | 7 |
|
|
2025
Q1 | $4.16M | Buy |
103,483
+37,600
| +57% | +$1.51M | 3.7% | 5 |
|
|
2024
Q4 | $3.1M | Buy |
65,883
+7,300
| +12% | +$343K | 2.33% | 19 |
|
|
2024
Q3 | $3.09M | Buy |
+58,583
| New | +$3.09M | 2.09% | 19 |
|
|
2024
Q2 | – | Sell |
-26,008
| Closed | -$1.82M | – | 58 |
|
|
2024
Q1 | $1.82M | Sell |
26,008
-8,900
| -25% | -$624K | 1.56% | 25 |
|
|
2023
Q4 | $2.91M | Buy |
+34,908
| New | +$2.91M | 2.88% | 11 |
|